Markets:

Overview

News

Currencies

International

Treasuries

Teva Pharmaceutical Industries Limited American Depositary Shares (NY:TEVA)

34.22 -0.11 (-0.32%)

Official Closing Price Updated: 4:10 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Teva Pharmaceutical Industries Limited American Depositary Shares

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

22 23 Next >

Teva Pharmaceutical Indus: Q1 Earnings Insights ↗

May 10, 2023

Via Benzinga

Nasdaq, S&P 500 Futures Slip Ahead Of Inflation Data — But Analyst Hints It Still Might Be Ok To Be Bullish ↗

May 10, 2023

Via Benzinga

Disney, Occidental Petroleum And 3 Stocks To Watch Heading Into Wednesday ↗

May 10, 2023

With US stock futures trading slightly higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

Investor Sentiment Improves Slightly Ahead Of Key Inflation Reports ↗

May 10, 2023

The CNN Money Fear and Greed index showed slight improvement in overall sentiment among U.S. investors on Tuesday.

Via Benzinga

Busy Week Ahead As Volatility Gauges Flash Red ↗

May 08, 2023

With CPI data being released on Wednesday and the Biden administration starting talks with Congress on Tuesday, it looks like this could be a big week for volatility.

Via Talk Markets

FDA Approves Teva/MedinCell's Antipsychotic Injection For Adult Schizophrenia Patients ↗

May 01, 2023

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

April 19, 2023

Via Benzinga

Merck Nabs Prometheus Bio For $10.8 Billion As Keytruda Patent Expirations Loom ↗

April 17, 2023

Merck is branching into immune-mediated diseases with this takeover.

Via Investor's Business Daily

1 "Safe" Stock to Avoid and 1 to Consider Buying in April ↗

April 15, 2023

There's more to the concept of safety than having a business model that looks safe.

Via The Motley Fool

Boeing, Spirit AeroSystems And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

April 14, 2023

U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Trillions In Biotech Stock Gains Trace Back To This Financier ↗

April 13, 2023

Frank did not grow up as son of a Wall Street banker. He began as the consummate outsider.

Via Investor's Business Daily

Why Teva Pharmaceutical Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

April 14, 2023

Gainers SAI.TECH Global Corporation (NASDAQ: SAI) jumped 269% to $5.61 after gaining around 25% on Thursday.

Via Benzinga

Emergent BioSolutions Soars: Analyst Upgrades Stock With Near 100% Upside After FDA's Positive Move ↗

April 10, 2023

Via Benzinga

7 A-Rated Stocks to Buy for April 2023 ↗

April 07, 2023

Now that the first quarter's in the bank, here are seven A-rated stocks to buy for April to keep your portfolio in top-notch shape.

Via InvestorPlace

The Byzantine Adderall Shortage Puts Teva And Others In The Hot Seat ↗

April 05, 2023

Millions of people are scrambling to get their ADHD medication. Here's why.

Via Investor's Business Daily

Stage Set For Generics As Biden Admin Asks Supreme Court To Hear Skinny Labels Case Between GSK, Teva ↗

March 31, 2023

Via Benzinga

Is Big Pharma Coming For Your Cannabis Business? ↗

March 27, 2023

Cannabis stocks have struggled in the market in recent years as the industry push to gain ground on the regulatory front hasn't progressed as quickly as investors had hoped. Yet beverage companies...

Via Benzinga

7 Strong Buy Stocks Under $10 to Snap Up Now ↗

March 23, 2023

Markets are missing out on these seven strong buy stocks under $10, which trade at too good a value score for savvy investors to ignore.

Via InvestorPlace

3 No-Brainer Stocks to Buy With $10 Right Now ↗

March 22, 2023

You don't need a large pile of money to begin building wealth on Wall Street.

Via The Motley Fool

Catalyst Pharma The No. 1 Biotech, Just Crushed 2023 Guidance Estimates ↗

March 15, 2023

The guidance includes Catalyst's newest, and second, product.

Via Investor's Business Daily

7 Core Stocks to Build a Solid Portfolio Around ↗

March 13, 2023

You’ll enjoy your investing journey more if you know that you can rely on your core of stocks to buy to provide a solid foundation.

Via InvestorPlace

BRTX’s ThermoStem®: A New Weapon In The Fight Against Metabolic Syndrome

March 09, 2023

BRTX’s ThermoStem®: A New Weapon In The Fight Against Metabolic Syndrome

Via News Direct

BRTX's ThermoStem®: A New Weapon In The Fight Against Metabolic Syndrome ↗

March 08, 2023

Metabolism is the chemical process whereby the body produces energy from food. By breaking down carbohydrates and fats into sugars, the cells access fuel that can be used or stored via the liver or...

Via Benzinga

Better Generics Pharmaceutical Stock: Teva or Viatris? ↗

March 05, 2023

Both have plans to return to growth.

Via The Motley Fool

7 Smart Stock Picks for Cautious Investors ↗

February 28, 2023

As market volatility continues, consider playing it safe with these seven high-quality stocks for cautious investors.

Via InvestorPlace

Walmart, Home Depot And 3 Stocks To Watch Heading Into Tuesday ↗

February 21, 2023

With US futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

A Patent Cliff Is Coming For Bristol — Can Billions In New Products Fill The Gap? ↗

February 17, 2023

The company's biggest moneymakers are soon to lose patent protection.

Via Investor's Business Daily

Axsome Therapeutics (AXSM) Stock Falls as Teva Pursues Generic Depression Drug ↗

February 13, 2023

Axsome Therapeutics (AXSM) stock is taking a beating on Monday as rival Teva Pharmaceutical (TEVA) prepares a generic depression drug.

Via InvestorPlace

Teva Plots Its Knockoff Of Axsome's New Depression Drug, Sending The Biotech Sprawling ↗

February 13, 2023

The company only just gained approval for its depression drug in August.

Via Investor's Business Daily

Teva Pharmaceutical Industries (TEVA) Q4 2022 Earnings Call Transcript ↗

February 08, 2023

TEVA earnings call for the period ending December 31, 2022.

Via The Motley Fool

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Teva Pharmaceutical Industries Limited American Depositary Shares (NY:TEVA)

Headline News about Teva Pharmaceutical Industries Limited American Depositary Shares

Starting at $3.75/week.

Subscribe Today